October 17 – 19 2017 | Boston, MA

Hilton Boston/Woburn

Pre-Conference Workshop
Tuesday, October 17, 2017

13.00 - 17.00
Navigating CDx Co-Development: What are the Decisions I Need to Make Today that Won’t Haunt Me 5 Years from Now?

Join Covance and their panel of industry expert speakers before the start of World CDx in this workshop to take a deeper dive into the strategy behind drug and companion diagnostic co-development. Benefit from multi-stakeholder perspectives, granular discussion and extended networking with the brightest biomarker, precision medicine and diagnostic minds in the field. The format for the workshop will be three 50 minute tracks, followed by a 30 minute keynote panel.

 

Topic One: Regulatory framework

  • Your diagnostic may not be a CDx yet – the data will determine that. But if the data isn’t collected in the appropriate regulatory framework, you can’t file.

 

Topic Two: Platform

  • Emerging technologies are seductive, but the availability of a diagnostic test hinges on the scale / application of a given technology. How do you assess fit?

 

Topic Three: Commercialization

  • On your therapeutic’s day of approval, you’ve got drugs in the warehouse waiting to be shipped – but diagnostics are different. Kits haven’t been developed, and there’s zero demand for them. And without CDx availability, your newly approved drug sits idle. How to ensure adequate access both the drug and the CDx on Day 1?

 

Speakers confirming from Covance, Payers, IVD developers, Biopharma

 

How to Apply

If you are interested in joining the pre-conference workshop hosted by Covance, please email ben.carrington@hansonwade.com.

 

If accepted, the workshop will be free to attend as part of your conference registration. Confirmation of attendance will be given via email.